As such, the disturbances in the mineral homeostasis start early in kidney disease with a reduction of α-Klotho and an increase in fibroblast growth factor 23 (FGF23), this is followed by a downregulation of the active vitamin D metabolite 1,25 dihydroxy vitamin D3 (1,25 vitamin D). Here, FGF23 is linked to kidney disorder.